Republican-led House passes bill restricting abortion

By Rachelle Younglai WASHINGTON (Reuters) – The Republican-controlled House of Representatives on Tuesday passed legislation severely restricting abortions, a move that could alienate women from the conservative party. The bill would ban abortions 20 weeks after fertilization occurs, a time when a fetus begins to feel pain, Republicans said. The legislation makes exceptions for victims of rape and incest as long as they first report the crime to authorities. The bill has no chance of becoming law with Democrats controlling the Senate and the White House threatening to veto it. …

Melissa Etheridge Calls Angelina Jolie’s Mastectomy ‘the Most Fearful Choice You Can Make’

Angelina Jolie arrives for the world premiere of her fiance Brad Pitt's film World War Z in LondonBy Tony Maglio LOS ANGELES (TheWrap.com) – Melissa Etheridge believes Angelina Jolie jumped the gun with her double mastectomy. The singer, a breast cancer survivor, told The Washington Blade that she has the same BRCA gene mutation as Jolie. When asked about Jolie's choice to undergo a preventative double mastectomy, Etheridge called Jolie's decision "the most fearful choice you can make when confronting anything with cancer." "I wouldn't call it the brave choice," the singer said. …

Outbreak of deadly piglet virus spreads to 13 U.S. states

By P.J. Huffstutter CHICAGO (Reuters) – A swine virus deadly to young pigs, one never before seen in North America, is spreading rapidly across the United States and proving harder to control than previously believed. The virus now has spread to 13 states – with more than 100 positive cases to date – since it was first diagnosed in the United States last month, said Montserrat Torremorell, the Allen D. Leman Chair in Swine Health and Productivity at the University of Minnesota’s College of Veterinary Medicine. …

Call for overhaul of drug industry business model

By Ben Hirschler LONDON (Reuters) – Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says. After years of disappointing research and development (R&D) productivity, a new report backed by leading institutional investors sees “early indications of a recovery”, with U.S. approvals of new drugs last year the highest since 1996. …

1 36 37 38 39 40 101